Przejdź do
Wybierz wielkość
| Rozmiar/SKU | Dostępność | Cena netto |
|---|
Informacje o tej pozycji
grade
pharmaceutical analytical impurity (PAI)
agency
USP
manufacturer/tradename
USP
application(s)
pharmaceutical small molecule
format
neat
storage temp.
-10 to -25°C
SMILES string
CC12CC3CC(C1)(CC(C3)(C2)NC4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O)C
InChI
InChI=1S/C24H41NO10/c1-22-3-11-4-23(2,8-22)10-24(5-11,9-22)25-20-17(31)16(30)19(13(7-27)33-20)35-21-18(32)15(29)14(28)12(6-26)34-21/h11-21,25-32H,3-10H2,1-2H3/t11?,12-,13-,14-,15+,16-,17-,18-,19-,20?,21+,22?,23?,24?/m1/s1
InChI key
IDHWSQNFOHZVMN-LLTBUSFYSA-N
General description
Analysis Note
1 of 1
Ta pozycja | |||
|---|---|---|---|
| description Pharmaceutical Analytical Impurity (PAI) | description pharmaceutical analytical impurity (PAI) | description United States Pharmacopeia (USP) Reference Standard | description pharmaceutical analytical impurity (PAI) |
| application(s) pharmaceutical small molecule | application(s) pharmaceutical small molecule | application(s) pharmaceutical (small molecule) | application(s) pharmaceutical small molecule |
| format neat | format neat | format neat | format neat |
| grade pharmaceutical analytical impurity (PAI) | grade pharmaceutical analytical impurity (PAI) | grade pharmaceutical primary standard | grade pharmaceutical analytical impurity (PAI) |
| storage temp. -10 to -25°C | storage temp. 2-30°C | storage temp. 2-8°C | storage temp. 2-8°C |
| manufacturer/tradename USP | manufacturer/tradename USP | manufacturer/tradename USP | manufacturer/tradename USP |
| agency USP | agency USP | agency USP | agency USP |
Słowo ostrzegawcze
Warning
Kody zagrożeń
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2
Klasa składowania
11 - Combustible Solids
Temperatura zapłonu (°F)
Not applicable
Temperatura zapłonu (°C)
Not applicable
Wybierz jedną z najnowszych wersji:
Masz już ten produkt?
Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

